Glycan Therapeutics Corporation
Raleigh, NC Doing business as Biotechnology Research
- UEI
- KYG3DZSMH4R7
- CAGE
- 6XZ77
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- Corporate family
-
-
Glycan Therapeutics Corporation
KYG3DZSMH4R7
- Glyco Discoveries, Inc. PFBMHRWCG2G1
-
Glycan Therapeutics Corporation
KYG3DZSMH4R7
- SAM.gov registration date
- Physical address
- 617 Hutton St #101, Raleigh, NC 27606, USA
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
About Glycan Therapeutics Corporation
Glycan Therapeutics Corporation is a corporate entity that provides research and development services related to glycosaminoglycans through federal grants. The company specializes in synthesizing sulfated carbohydrates such as heparan sulfate using innovative enzyme-based methods.
Glycan Therapeutics has received over $17 million in federal prime and sub awards from the Department of Health and Human Services' National Institutes of Health to support research on glycosaminoglycans. This includes multiple project grants from the National Institute of General Medical Sciences through programs like Biomedical Research and Research Training (CFDA 93.859). Specifically, Glycan Therapeutics develops synthetic heparan sulfate oligosaccharides to serve as research tools and potential therapeutics, quantifies and analyzes glycosaminoglycans from biological sources, and constructs methods to study interactions between sulfated glycans like chondroitin sulfate and proteins. Additional services provided via federal grants include pharmacodynamic analysis in animal models, process development and scale up of chemical manufacturing, and preclinical toxicology studies.
Quick answers
What is Glycan Therapeutics Corporation's UEI?
Glycan Therapeutics Corporation's Unique Entity ID (UEI) in SAM.gov is KYG3DZSMH4R7.
What is Glycan Therapeutics Corporation's CAGE code?
Glycan Therapeutics Corporation's CAGE code is 6XZ77.
What is Glycan Therapeutics Corporation's primary NAICS code?
Glycan Therapeutics Corporation's primary NAICS code is 325414 (Biological Product (except Diagnostic) Manufacturing).
Where is Glycan Therapeutics Corporation located?
Glycan Therapeutics Corporation's physical address in SAM.gov is 617 Hutton St #101, Raleigh, NC 27606, USA.
Is Glycan Therapeutics Corporation registered in SAM.gov?
Yes. Glycan Therapeutics Corporation's SAM.gov registration is active through June 24, 2027.
What is Glycan Therapeutics Corporation's most recent federal award?
Glycan Therapeutics Corporation's most recent federal grant award is Synthesis of the library of heparan sulfate hexasaccharide mimetics - project summary: heparan sulfate (HS) play roles… (R44GM145004), from National Institute of General Medical Sciences, on September 21, 2023.
On GovTribe
See Glycan Therapeutics Corporation's full federal record
- Federal contract awards
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors